| 000 | 01003 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518031151.0 | ||
| 264 | 0 | _c20200214 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1558-3597 | ||
| 024 | 7 |
_a10.1016/j.jacc.2019.01.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnand, Inder S | |
| 245 | 0 | 0 |
_aWhat Explains the Benefits of ARNI Therapy in Heart Failure? _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _c03 2019 |
||
| 300 |
_a1285-1287 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAminobutyrates |
| 650 | 0 | 4 | _aBiphenyl Compounds |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aHeart Failure |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNatriuretic Peptide, Brain |
| 650 | 0 | 4 | _aTetrazoles |
| 650 | 0 | 4 | _aValsartan |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 73 _gno. 11 _gp. 1285-1287 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacc.2019.01.019 _zAvailable from publisher's website |
| 999 |
_c29503646 _d29503646 |
||